Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy

Abstract excerpt

Immunotherapy has emerged as a crucial strategy to combat cancer by "reprogramming" a patient's own immune system. Although immunotherapy is typically reserved for patients with a high mutational burden, neoantigens produced from posttranscriptional regulation may provide an untapped reservoir of common immunogenic targets for new targeted therapies. To comprehensively define tumor-specific and likely immunogenic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to interferon and immune responses
• Share to Monoclonal and Polyclonal Antibodies Research
• Share to RNA and protein synthesis mechanisms